A Randomized Trial of Pessary in Singleton Pregnancies with a Short Cervix

  • STATUS
    Recruiting
  • participants needed
    100
Updated on 19 February 2024

Summary

Preterm birth is the primary driver of perinatal morbidity and mortality affecting approximately 11% of all newborns in the United States.1 Of the 4 million neonatal deaths that occur annually around the world, more than a quarter are the result of preterm birth.2 A short cervix by ultrasound has been noted to be one of the strongest predictors of subsequent preterm birth and investigators have focused efforts in finding a treatment for women with a short cervix that will reduce the risk of preterm delivery. Although vaginal progesterone and cerclage have been shown to reduce the risk, results have not been uniformly positive, and a low-cost, simple and effective method would be of great value, especially globally. The cervical pessary is such a treatment. This randomized trial will evaluate whether a cervical pessary can reduce the risk of preterm birth before 37 weeks in women with a short cervix.

Details
Condition ['Short Cervix', 'Preterm Delivery']
Age 99years or below
Clinical Study IdentifierTBD
Last Modified on19 February 2024

Eligibility

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.